Jeffrey L. Anderson

发表

Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).

B. Horne, H. May, R. Pearson, 2008, The American journal of cardiology.

Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes.

H. May, D. Lappé, T. Bair, 2013, Heart rhythm.

Warfarin Knowledge in Patients with Atrial Fibrillation: Implications for Safety, Efficacy, and Education Strategies

B. Horne, D. Lappé, Jeffrey L. Anderson, 2010, Cardiology.

Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring.

H. May, T. Bair, Jeffrey L. Anderson, 2014, Mayo Clinic proceedings.

The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.

H. May, T. Bair, Jeffrey L. Anderson, 2015, Heart rhythm.

Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe

D. Lappé, Jeffrey L. Anderson, T. Bunch, 2017, Journal of cardiovascular electrophysiology.

Long-Term Natural History of Adult Wolff–Parkinson–White Syndrome Patients Treated With and Without Catheter Ablation

H. May, T. Bair, M. Cutler, 2015, Circulation. Arrhythmia and electrophysiology.

Free thyroxine within the normal reference range predicts risk of atrial fibrillation

H. May, D. Lappé, T. Bair, 2020, Journal of cardiovascular electrophysiology.

Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes

B. Horne, H. May, J. Carlquist, 2013, Thrombosis and Haemostasis.

Spectrum of radionuclide perfusion study abnormalities in takotsubo cardiomyopathy

B. Horne, T. Bair, Jeffrey L. Anderson, 2020, Journal of Nuclear Cardiology.